Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases

Li W., Li H., Fan L., Zhao R., Dong F., Jia X.

Clinical Trial on Chronic Wound, Scar, Skin Aging, Hair Regeneration, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Int J Nanomedicine (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41127790
PMCID
PMC12537804
DOI
10.2147/ijn.s547871
Citations
3

Abstract (original English)

Exosomes, owing to their potent capabilities for intercellular communication, have great potential in modern medicine. The pathogenesis of skin diseases is predominantly characterized by immune imbalance and impaired regenerative processes. Exosomes are rich in microRNAs, lipids, and proteins, which play a crucial role in immune regulation and regenerative medicine. Recent studies have highlighted the involvement of exosomes in the therapeutic management of dermatological disorders. This review provides a comprehensive overview of the potential therapeutic applications of exosomes in autoimmune skin conditions, such as systemic lupus erythematosus, systemic sclerosis, psoriasis, and vitiligo, as well as their roles in skin wound healing, skin aging, scar formation, skin flap regeneration, hair regeneration, and other skin regenerative disorders. The paper examines various exosome delivery methods and evaluates current clinical trials, identifying challenges related to exosome isolation, preservation, active components, mechanistic understanding, and clinical translation. Furthermore, it delineates future research directions and proposes innovative strategies for advancing exosome-based therapies in dermatology.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
HumansSkin DiseasesAutoimmune DiseasesMicroRNAsDrug Delivery SystemsExosomesBiomarkers

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research